主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Roderick Wong | 否 | 1543.96万 | 39.15% | 新增 | 新增 | -- |
| 2 | Tang Capital Partners, LP | 是 | 266.55万 | 6.76% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-11-18 | Shah Gaurav |
|
77.83 | 2.98 | 是 | CEO |
| 2025-11-18 | Schwartz Jonathan David |
|
29.91 | 2.98 | 是 | Chief Science & Gene Therapy Officer |
| 2025-11-18 | Militello John |
|
6.59 | 2.98 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-11-18 | Wilson Martin |
|
38.38 | 2.98 | 是 | General Counsel |
| 2025-11-03 | Wilson Martin |
|
38.55 | 0.00 | 是 | General Counsel |
| 2025-10-14 | Militello John |
|
7.61 | 3.96 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-10-14 | Militello John |
|
7.06 | 3.97 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-10-14 | Militello John |
|
6.76 | 3.97 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-10-14 | Militello John |
|
6.70 | 3.98 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-10-06 | Rizvi Syed Ali-aamir |
|
28.30 | 0.00 | 是 | Chief Medical Officer |
| 2025-10-06 | Rizvi Syed Ali-aamir |
|
34.59 | 0.00 | 是 | Chief Medical Officer |
| 2025-09-24 | Fong Peter |
|
2.33 | 0.00 | 是 | -- |
| 2025-09-24 | Fong Peter |
|
5.33 | 0.00 | 是 | -- |
| 2025-09-08 | Schwartz Jonathan David |
|
30.16 | 0.00 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-09-08 | Wilson Martin |
|
28.55 | 0.00 | 是 | General Counsel |
| 2025-09-08 | Militello John |
|
9.59 | 0.00 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-08-27 | Bjork Elisabeth |
|
4.00 | 3.41 | 是 | -- |
| 2025-08-18 | Wilson Martin |
|
13.55 | 3.00 | 是 | General Counsel |
| 2025-08-18 | Wilson Martin |
|
13.61 | 3.07 | 是 | General Counsel |
| 2025-08-18 | Shah Gaurav |
|
78.46 | 3.05 | 是 | CEO |
| 2025-08-18 | Schwartz Jonathan David |
|
22.24 | 3.07 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-08-18 | Schwartz Jonathan David |
|
22.16 | 3.00 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-08-18 | Militello John |
|
5.63 | 3.07 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-08-18 | Militello John |
|
5.59 | 3.00 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-08-14 | Wilson Martin |
|
13.71 | 3.02 | 是 | General Counsel |
| 2025-08-14 | Schwartz Jonathan David |
|
22.41 | 3.02 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-08-14 | Militello John |
|
5.70 | 3.02 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-08-04 | Stevens Christopher James |
|
40.72 | 0.00 | 是 | Chief Operating Officer |
| 2025-07-03 | Ondrey Aaron |
|
12.82 | 2.88 | 是 | Chief Financial Officer |
| 2025-06-18 | Pratumsuwan Piratip |
|
3.00 | 0.00 | 是 | -- |
| 2025-06-18 | SOUTHWELL DAVID P |
|
3.17 | 0.00 | 是 | -- |
| 2025-06-18 | BOESS CARSTEN |
|
3.00 | 0.00 | 是 | -- |
| 2025-06-18 | GRANADILLO PEDRO P |
|
3.00 | 0.00 | 是 | -- |
| 2025-06-18 | GRANADILLO PEDRO P |
|
5.47 | 0.00 | 是 | -- |
| 2025-06-18 | Dolsten Mikael |
|
4.42 | 0.00 | 是 | -- |
| 2025-06-18 | WONG RODERICK |
|
3.00 | 0.00 | 是 | -- |
| 2025-06-18 | WONG RODERICK |
|
4.77 | 0.00 | 是 | -- |
| 2025-06-18 | Malik Fady Ibraham |
|
3.00 | 0.00 | 是 | -- |
| 2025-06-18 | Bjork Elisabeth |
|
3.00 | 0.00 | 是 | -- |
| 2025-05-20 | Wilson Martin |
|
14.92 | 6.45 | 是 | General Counsel |
| 2025-05-20 | Shah Gaurav |
|
78.68 | 6.45 | 是 | CEO |
| 2025-05-20 | Schwartz Jonathan David |
|
23.53 | 6.45 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-05-20 | Militello John |
|
6.40 | 6.45 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-05-20 | Patel Kinnari |
|
44.19 | 6.45 | 是 | President, Head of R&D and Chief Operating Officer |
| 2025-05-16 | Militello John |
|
6.44 | 6.53 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-05-16 | Wilson Martin |
|
14.98 | 6.53 | 是 | General Counsel |
| 2025-05-16 | Shah Gaurav |
|
78.91 | 6.53 | 是 | CEO |
| 2025-05-16 | Patel Kinnari |
|
44.27 | 6.53 | 是 | President, Head of R&D and Chief Operating Officer |
| 2025-05-16 | Schwartz Jonathan David |
|
23.61 | 6.53 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-04-22 | Militello John |
|
6.50 | 7.16 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-04-10 | Shah Gaurav |
|
79.27 | 5.08 | 是 | CEO |
| 2025-04-04 | Ondrey Aaron |
|
12.97 | 5.29 | 是 | Chief Financial Officer |
| 2025-03-05 | Dolsten Mikael |
|
1.42 | 0.00 | 是 | -- |
| 2025-02-21 | Wilson Martin |
|
15.07 | 10.58 | 是 | General Counsel |
| 2025-02-21 | Shah Gaurav |
|
77.27 | 10.58 | 是 | CEO |
| 2025-02-21 | Patel Kinnari |
|
44.41 | 10.58 | 是 | President, Head of R&D and Chief Operating Officer |
| 2025-02-21 | Militello John |
|
6.58 | 10.58 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-02-11 | Patel Kinnari |
|
45.02 | 0.00 | 是 | President, Head of R&D and Chief Operating Officer |
| 2025-02-11 | Schwartz Jonathan David |
|
25.27 | 0.00 | 是 | Chief Medical & Gene Therapy Officer |
| 2025-02-11 | Shah Gaurav |
|
78.90 | 0.00 | 是 | CEO |
| 2025-02-11 | Ondrey Aaron |
|
13.71 | 0.00 | 是 | Chief Financial Officer |
| 2025-02-11 | Wilson Martin |
|
15.39 | 0.00 | 是 | General Counsel |
| 2025-02-11 | Militello John |
|
6.85 | 0.00 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2025-01-23 | Militello John |
|
4.84 | 10.38 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-11-21 | Militello John |
|
4.93 | 13.05 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-11-21 | Wilson Martin |
|
6.36 | 13.05 | 是 | General Counsel |
| 2024-11-21 | Shah Gaurav |
|
70.73 | 13.05 | 是 | CEO |
| 2024-11-21 | Patel Kinnari |
|
39.24 | 13.05 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-10-31 | White Mark Andrew |
|
6.91 | 16.63 | 是 | General Manager, Commercial Affairs |
| 2024-10-31 | Militello John |
|
5.05 | 16.63 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-08-16 | Militello John |
|
5.15 | 18.50 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-08-16 | Patel Kinnari |
|
39.70 | 18.50 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-08-16 | Shah Gaurav |
|
71.84 | 18.50 | 是 | CEO |
| 2024-08-16 | Wilson Martin |
|
6.47 | 18.50 | 是 | General Counsel |
| 2024-07-22 | Militello John |
|
5.25 | 23.02 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-07-08 | White Mark Andrew |
|
7.22 | 20.40 | 是 | General Manager, Commercial Affairs |
| 2024-05-17 | Schwartz Jonathan David |
|
16.97 | 23.35 | 是 | Chief Medical & Gene Therapy Officer |
| 2024-05-17 | Schwartz Jonathan David |
|
16.69 | 18.50 | 是 | Chief Medical & Gene Therapy Officer |
| 2024-05-17 | Schwartz Jonathan David |
|
16.39 | 13.05 | 是 | Chief Medical & Gene Therapy Officer |
| 2024-05-17 | Schwartz Jonathan David |
|
23.76 | 10.58 | 是 | Chief Medical & Gene Therapy Officer |
| 2024-05-16 | Militello John |
|
5.33 | 23.35 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-05-14 | Wilson Martin |
|
2.11 | 0.00 | 是 | General Counsel |
| 2024-05-14 | Wilson Martin |
|
4.99 | 0.00 | 是 | General Counsel |
| 2024-05-14 | Wilson Martin |
|
6.68 | 0.00 | 是 | General Counsel |
| 2024-05-14 | Wilson Martin |
|
6.58 | 23.35 | 是 | General Counsel |
| 2024-05-14 | Shah Gaurav |
|
63.65 | 0.00 | 是 | CEO |
| 2024-05-14 | Shah Gaurav |
|
64.61 | 0.00 | 是 | CEO |
| 2024-05-14 | Shah Gaurav |
|
67.01 | 0.00 | 是 | CEO |
| 2024-05-14 | Shah Gaurav |
|
73.79 | 0.00 | 是 | CEO |
| 2024-05-14 | Shah Gaurav |
|
72.81 | 23.35 | 是 | CEO |
| 2024-05-14 | Patel Kinnari |
|
29.63 | 0.00 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-05-14 | Patel Kinnari |
|
30.18 | 0.00 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-05-14 | Patel Kinnari |
|
31.38 | 0.00 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-05-14 | Patel Kinnari |
|
36.63 | 0.00 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-05-14 | Patel Kinnari |
|
40.50 | 0.00 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-05-14 | Patel Kinnari |
|
40.10 | 23.35 | 是 | President, Head of R&D and Chief Operating Officer |
| 2024-05-02 | SOUTHWELL DAVID P |
|
0.17 | 0.00 | 是 | -- |
| 2024-04-22 | Militello John |
|
5.44 | 22.87 | 是 | Vice President of Finance, Treasurer, Principal Accounting Officer |
| 2024-04-12 | SOUTHWELL DAVID P |
|
16.52 | 4.34 | 是 | -- |
| 2024-04-12 | SOUTHWELL DAVID P |
|
10.54 | 24.22 | 是 | -- |
| 2024-04-12 | SOUTHWELL DAVID P |
|
9.52 | 25.16 | 是 | -- |
| 2024-04-12 | SOUTHWELL DAVID P |
|
12.48 | 4.34 | 是 | -- |
| 2024-04-12 | SOUTHWELL DAVID P |
|
11.48 | 24.05 | 是 | -- |
| 2024-04-08 | White Mark Andrew |
|
7.52 | 24.64 | 是 | General Manager, Commercial Affairs |
| 2024-04-01 | Ondrey Aaron |
|
4.68 | 0.00 | 是 | Chief Financial Officer |
| 2024-03-21 | Militello John |
|
2.44 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-03-21 | Militello John |
|
3.24 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-03-21 | Militello John |
|
4.67 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-03-21 | Militello John |
|
5.77 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-03-21 | Militello John |
|
5.52 | 28.10 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-02-29 | Wilson Martin |
|
1.87 | 29.33 | 是 | General Counsel |
| 2024-02-29 | Militello John |
|
3.15 | 12.55 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-02-29 | Militello John |
|
2.15 | 29.85 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-02-16 | Wilson Martin |
|
0.61 | 29.84 | 是 | General Counsel |
| 2024-02-16 | Shah Gaurav |
|
62.13 | 0.00 | 是 | CEO |
| 2024-02-16 | Shah Gaurav |
|
55.48 | 29.84 | 是 | CEO |
| 2024-02-16 | Patel Kinnari |
|
27.16 | 0.00 | 是 | President & Chief Operating Officer |
| 2024-02-16 | Patel Kinnari |
|
23.83 | 29.84 | 是 | President & Chief Operating Officer |
| 2024-02-16 | Wilson Martin |
|
2.28 | 0.00 | 是 | General Counsel |
| 2024-02-16 | Militello John |
|
1.32 | 29.84 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-02-16 | Militello John |
|
2.15 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-02-16 | White Mark Andrew |
|
8.78 | 0.00 | 是 | Chief Medical Officer |
| 2024-02-14 | Militello John |
|
1.64 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-02-14 | Wilson Martin |
|
0.97 | 0.00 | 是 | General Counsel |
| 2024-02-14 | Shah Gaurav |
|
57.50 | 0.00 | 是 | CEO |
| 2024-02-14 | Patel Kinnari |
|
24.55 | 0.00 | 是 | President & Chief Operating Officer |
| 2024-01-22 | Militello John |
|
1.02 | 27.20 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |
| 2024-01-18 | Militello John |
|
1.08 | 0.00 | 是 | VP, Principal Accounting Officer and Interim Principal Financial Officer |